Integrated Dual Disorder Treatment
... • Sweating, constipation, abnormal libido, sleep abnormalities, mild anorexia, weight gain, water retention ...
... • Sweating, constipation, abnormal libido, sleep abnormalities, mild anorexia, weight gain, water retention ...
Switching opioids using equivalence tables
... Hydromorph Contin is available in 6 mg and 9 mg formulations. Base the dose decision on the patient’s pain history and risk factors for opioid adverse effects. o If the patient’s pain was not well-controlled on Oxycontin 50 mg BID and the patient is not at high risk for adverse effects, consider sta ...
... Hydromorph Contin is available in 6 mg and 9 mg formulations. Base the dose decision on the patient’s pain history and risk factors for opioid adverse effects. o If the patient’s pain was not well-controlled on Oxycontin 50 mg BID and the patient is not at high risk for adverse effects, consider sta ...
Law Enforcement Partnering to Reduce Opioid Overdose Deaths
... Overdose occurs when too much of an opioid substance fits into too many receptors in the brain, slowing and then stopping breathing. ...
... Overdose occurs when too much of an opioid substance fits into too many receptors in the brain, slowing and then stopping breathing. ...
medications used in the management of substance use disorders
... on ECG; risk of cardiac arrhythmias. • Discontinue or taper the methadone dose and consider an alternative therapy if the QTc > 500ms. • Plasma half-life may be longer than the analgesic duration. • Delayed analgesia or toxicity may occur because of drug accumulation after repeated doses, e.g., o ...
... on ECG; risk of cardiac arrhythmias. • Discontinue or taper the methadone dose and consider an alternative therapy if the QTc > 500ms. • Plasma half-life may be longer than the analgesic duration. • Delayed analgesia or toxicity may occur because of drug accumulation after repeated doses, e.g., o ...
Acute pain relief at a teaching Hospital
... P+C = 1 g paracetamol plus 60 mg codeine; D+P = single oral dose 100-mg enteric-coated diclofenac with 1 g paracetamol; D+P+C = 100-mg enteric-coated diclofenac with 1 g paracetamol plus 60 mg codeine ...
... P+C = 1 g paracetamol plus 60 mg codeine; D+P = single oral dose 100-mg enteric-coated diclofenac with 1 g paracetamol; D+P+C = 100-mg enteric-coated diclofenac with 1 g paracetamol plus 60 mg codeine ...
benzodiazpines
... – increased risk of accidents – adverse sleep effects – dependence and withdrawal (even at therapeutic doses) • BZDs have an additive effect with alcohol / other CNS depressants, increasing the risk of harm • BZDs have limited long-term efficacy. Benzodiazepines ...
... – increased risk of accidents – adverse sleep effects – dependence and withdrawal (even at therapeutic doses) • BZDs have an additive effect with alcohol / other CNS depressants, increasing the risk of harm • BZDs have limited long-term efficacy. Benzodiazepines ...
3 Narcotics
... DEMEROL (1930's) 15% of morphine's effectiveness dose 50-150mg/4h (up to 75mg if by i.v.) NO nausea, no affect on pupils CAUSES sedation, euphoria and is addictive MORPHINE AGONIST, goes to same receptor sites ...
... DEMEROL (1930's) 15% of morphine's effectiveness dose 50-150mg/4h (up to 75mg if by i.v.) NO nausea, no affect on pupils CAUSES sedation, euphoria and is addictive MORPHINE AGONIST, goes to same receptor sites ...
Name: Paracetamol
... paracetamol is only available for self-selection by patients from a pharmacy. The Pamol product range has been available at this level of classification for several years. Paracetamol is classed as an analgesic/antipyretic which is commonly used to relieve pain and fever. Paracetamol in tablet and c ...
... paracetamol is only available for self-selection by patients from a pharmacy. The Pamol product range has been available at this level of classification for several years. Paracetamol is classed as an analgesic/antipyretic which is commonly used to relieve pain and fever. Paracetamol in tablet and c ...
Tricyclic Antidepressants
... 2. With tricyclic antidepressants which of the following are true: a. TCA’s are easily cleared by hemodialysis, hemofiltration and forced diuresis b. Due to negative cardiac inotrophy, pulmonary edema is common c. Aggressive sodium bicarbonate therapy is the treatment of choice for widened QRS/QTc d ...
... 2. With tricyclic antidepressants which of the following are true: a. TCA’s are easily cleared by hemodialysis, hemofiltration and forced diuresis b. Due to negative cardiac inotrophy, pulmonary edema is common c. Aggressive sodium bicarbonate therapy is the treatment of choice for widened QRS/QTc d ...
(Brompheniramine Maleate 2 mg, Pseudoephedrine
... A 21 /2-year-old child survived the ingestion of 21 mg/kg of dextromethorphan exhibiting only ataxia, drowsiness, and fever, but seizures have been reported in 2 children following the ingestion of 13-17 mg/kg. Another 21 /2-year-old child survived a dose of 300-900 mg of brompheniramine. The toxic ...
... A 21 /2-year-old child survived the ingestion of 21 mg/kg of dextromethorphan exhibiting only ataxia, drowsiness, and fever, but seizures have been reported in 2 children following the ingestion of 13-17 mg/kg. Another 21 /2-year-old child survived a dose of 300-900 mg of brompheniramine. The toxic ...
Opioid Aware - North Essex Partnership University NHS Foundation
... 2. A small proportion of people may obtain good pain relief with opioids in the long-term if the dose can be kept low and especially if their use is intermittent (however it is difficult to identify these people at the point of opioid initiation). 3. The risk of harm increases substantially at doses ...
... 2. A small proportion of people may obtain good pain relief with opioids in the long-term if the dose can be kept low and especially if their use is intermittent (however it is difficult to identify these people at the point of opioid initiation). 3. The risk of harm increases substantially at doses ...
Opioid withdrawals
... WITHDRAWAL Partial opioid agonist useful in managing heroin withdrawal. Day 1: 4 to 8 mg Day 2: 4 to 12 mg Day 3: 4 to 16 mg Day 4: 2 to 12 mg Day 5: 0 to 8 mg Day 6: 0 to 4 mg Day 7: 0 to 2 mg Day 8: 0 to 1 mg ...
... WITHDRAWAL Partial opioid agonist useful in managing heroin withdrawal. Day 1: 4 to 8 mg Day 2: 4 to 12 mg Day 3: 4 to 16 mg Day 4: 2 to 12 mg Day 5: 0 to 8 mg Day 6: 0 to 4 mg Day 7: 0 to 2 mg Day 8: 0 to 1 mg ...
ASX Announcement
... Butalbital and acetaminophen tablets, 50mg/300mg are indicated for the relief of the symptom of complex tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this r ...
... Butalbital and acetaminophen tablets, 50mg/300mg are indicated for the relief of the symptom of complex tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this r ...
Phenanthrenes - Iowa Dental Association
... New prescribing guidelines in response to serious adverse events Manufacturer not liable for adverse outcomes if practitioner uses medication outside of labeling Emphasizes the importance of proper patient selection criteria for all NSAIDS ...
... New prescribing guidelines in response to serious adverse events Manufacturer not liable for adverse outcomes if practitioner uses medication outside of labeling Emphasizes the importance of proper patient selection criteria for all NSAIDS ...
Nucleoside/Nucleotide reverse transcriptase inhibitors
... headache, vomiting, dry skin. Both forms should be taken at least one hour before meals or two hours after meals. Avoid the use of antacid tablets with aluminum if taking tablets or powder form. When combined with Viread®, the dose should be reduced to 250 mg a day. ...
... headache, vomiting, dry skin. Both forms should be taken at least one hour before meals or two hours after meals. Avoid the use of antacid tablets with aluminum if taking tablets or powder form. When combined with Viread®, the dose should be reduced to 250 mg a day. ...
robaxin®/robaxin®-750 (methocarbamol tablets, USP)
... saccharin so dium, so dium lauryl sulfate, so dium starch g lyco late, stearic acid, titanium dio xide. ro baxin® -750 is available as an o rang e capsule-shaped, film-co ated tablet co ntaining 750 mg o f metho carbamo l, USP fo r o ral administratio n. In additio n to the inactive ing redients pre ...
... saccharin so dium, so dium lauryl sulfate, so dium starch g lyco late, stearic acid, titanium dio xide. ro baxin® -750 is available as an o rang e capsule-shaped, film-co ated tablet co ntaining 750 mg o f metho carbamo l, USP fo r o ral administratio n. In additio n to the inactive ing redients pre ...
paracetamol, diphenhydramine hydrochloride
... The speed of absorption of paracetamol may be increased by metoclopramide or domperidone and absorption reduced by colestyramine. The anti-coagulant effect of warfarin and other coumarins may be enhanced by prolonged regular use of paracetamol with increased risk of bleeding; occasional doses have n ...
... The speed of absorption of paracetamol may be increased by metoclopramide or domperidone and absorption reduced by colestyramine. The anti-coagulant effect of warfarin and other coumarins may be enhanced by prolonged regular use of paracetamol with increased risk of bleeding; occasional doses have n ...
Furosemide Edema, initial dose: 20-40 mg/dose IV or IM
... Continuous infusion: 20-40 mg bolus IV, followed by 1040 mg/hour. Double the rate every 2 hours, up to a maximum 80-160 mg/hour. Edema, initial dose: 0.5-1 mg IV or IM. Repeat in 2-3 hours if response is inadequate, up to a maximum of 10 mg/day. Edema, maintenance dose: give the effective dose (from ...
... Continuous infusion: 20-40 mg bolus IV, followed by 1040 mg/hour. Double the rate every 2 hours, up to a maximum 80-160 mg/hour. Edema, initial dose: 0.5-1 mg IV or IM. Repeat in 2-3 hours if response is inadequate, up to a maximum of 10 mg/day. Edema, maintenance dose: give the effective dose (from ...
Table 2. Dosage regimens of injectable loop diuretics7
... Continuous infusion: 20-40 mg bolus IV, followed by 1040 mg/hour. Double the rate every 2 hours, up to a maximum 80-160 mg/hour. Edema, initial dose: 0.5-1 mg IV or IM. Repeat in 2-3 hours if response is inadequate, up to a maximum of 10 mg/day. Edema, maintenance dose: give the effective dose (from ...
... Continuous infusion: 20-40 mg bolus IV, followed by 1040 mg/hour. Double the rate every 2 hours, up to a maximum 80-160 mg/hour. Edema, initial dose: 0.5-1 mg IV or IM. Repeat in 2-3 hours if response is inadequate, up to a maximum of 10 mg/day. Edema, maintenance dose: give the effective dose (from ...
Evidence for Appropriate Pain Treatment Guidelines
... Larger dose required to maintain original effects (analgesic and AE’s) Interindividual variability in development of tolerance “There appears to be no limit to the development of tolerance, and with appropriate dose adjustments, patients can continue to obtain pain relief.”—Inturrisi C. Clin J Pain ...
... Larger dose required to maintain original effects (analgesic and AE’s) Interindividual variability in development of tolerance “There appears to be no limit to the development of tolerance, and with appropriate dose adjustments, patients can continue to obtain pain relief.”—Inturrisi C. Clin J Pain ...
What is Fentanyl? - Drug and Alcohol Nurses Australasia
... Supervision of injecting episodes that might otherwise occur in less safe circumstances such as public places or alone A safer environment where immediate medical assistance is available if required Access to health & social welfare services for a marginalised & difficult to reach population ...
... Supervision of injecting episodes that might otherwise occur in less safe circumstances such as public places or alone A safer environment where immediate medical assistance is available if required Access to health & social welfare services for a marginalised & difficult to reach population ...
20808 AlleRx PE.indd
... reserpine and veratrum alkaloids. Additive anticholinergic effects may result from concomitant use with antipsychotics, tricyclic antidepressants, and other drugs with anticholinergic effects. Concomitant administration with antacids may interfere with the absorption of methscopolamine nitrate. Carc ...
... reserpine and veratrum alkaloids. Additive anticholinergic effects may result from concomitant use with antipsychotics, tricyclic antidepressants, and other drugs with anticholinergic effects. Concomitant administration with antacids may interfere with the absorption of methscopolamine nitrate. Carc ...
Table 17. Specific Drug Information for ER/LA Opioid
... Opioid-naive patients: initiate treatment with 10 mg every 12 hours. Titrate using a minimum of 1- to 2-day intervals. Hepatic impairment: start with one-third to one-half the usual dosage. Renal impairment (creatinine clearance <60 mL/min): start with onehalf the usual dosage. Consider use of oth ...
... Opioid-naive patients: initiate treatment with 10 mg every 12 hours. Titrate using a minimum of 1- to 2-day intervals. Hepatic impairment: start with one-third to one-half the usual dosage. Renal impairment (creatinine clearance <60 mL/min): start with onehalf the usual dosage. Consider use of oth ...
Dextropropoxyphene
Dextropropoxyphene is an analgesic in the opioid category, patented in 1955 and manufactured by Eli Lilly and Company. It is an optical isomer of levopropoxyphene. It is intended to treat mild pain and also has antitussive (cough suppressant) and local anaesthetic effects. The drug has been taken off the market in Europe and the US due to concerns of fatal overdoses and heart arrhythmias. Its onset of analgesia (pain relief) is said to be 20–30 minutes and peak effects are seen about 1.5–2 hours after oral administration.Dextropropoxyphene is sometimes combined with acetaminophen or aspirin. Trade names include Darvocet-N and Di-Gesic, Darvon with APAP (for dextropropoxyphene and paracetamol) and Darvon with ASA (for dextropropoxyphene and aspirin). The British approved name (i.e. the generic name of the active ingredient) of the paracetamol/dextropropoxyphene preparation is ""co-proxamol"" (sold under a variety of brand names); however, it has been withdrawn since 2007, and is no longer available to new patients, with exceptions. The paracetamol combination(s) are known as Capadex or Di-Gesic in Australia, Lentogesic in South Africa, and Di-Antalvic in France (unlike co-proxamol, which is an approved name, these are all brand names).Dextropropoxyphene is known under several synonyms, including: Alpha-d-4-dimethylamino-3-methyl-1,2-diphenyl-2-butanol propionate [(2S,3S)-4-(Dimethylamino)-3- methyl-1,2-diphenylbutan-2-yl] propanoate (+)-1,2-Diphenyl-2-propionoxy- 3-methyl-4-di-methylaminobutane Desoxypropiophen↑ 1.0 1.1 1.2 1.3 1.4 ↑ ↑ ↑ ↑ ↑ ↑ ↑